Home  > 
News
  Prometic announces positive interim clinical data from IVIG phase 3 trial in patients with PID,   November 24, 2017
  Khondrion presents positive phase II KHENERGY trial data of oral KH176 in mitochondrial disease at Dutch Life Sciences conference,   November 23, 2017
  Exelixis to present phase 3 CELESTIAL trial results of cabozantinib at ASCO-GI Symposium,   November 23, 2017
  BiondVax, NIH sign CTA for phase 2 trial in US with universal flu vaccine,   November 22, 2017
  IMpower150 study shows atezolizumab significantly improves PFS in patients with NSCLC compared with chemotherapy,   November 22, 2017
  Daiichi Sankyo begins phase 2 study of DS-8201 in patients with HER2-positive advanced gastric cancer,   November 22, 2017
  BioLineRx partial results of BL-8040 COMBAT study accepted for presentation at ASCO 2018 Gastrointestinal Cancers Symposium,   November 21, 2017
  Adocia announces positive results from phase 1 study of BioChaperone Glucagon,   November 21, 2017
  Chugai Pharma’s phase III HAVEN 3 study evaluating emicizumab meets primary endpoint,   November 21, 2017
  Roche's phase III IMpower150 study meets co-primary endpoint of progression-free survival,   November 21, 2017
  Sobi begins phase 3 study evaluating safety and efficacy of anakinra to treat Still’s disease,   November 20, 2017
  Zydus’ oral anaemia developmental candidate, ZYAN1 named as Desidustat by WHO,   November 20, 2017
  Egalet reports positive results from phase 3 study of Egalet-002,   November 20, 2017
  Wellthy Therapeutics conducts first made-in-India ‘digital pill’ clinical trial for diabetes,   November 18, 2017
  CRF Health’s TrialMax Touch selected by leading specialty pharma company for padiatric rare disease phase II study,   November 16, 2017
  Data from landmark NIH blood pressure study supports important part of new AHA/ACC hypertension guidelines,   November 15, 2017
  New data reinforces clinical basis for switching to Sandoz biosimilar medicines,   November 15, 2017
  Novartis announces positive results from two phase III studies of brolucizumab versus aflibercept,   November 14, 2017
  NousCom announces 'preclinical data of neoantigen-based cancer vaccine in combo with Nektar Therapeutics' NKTR-214,   November 14, 2017
  Donor corneas can be safely preserved for longer period: NIH study,   November 14, 2017

 Back
 
PITS_2017
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |